ATE173259T1 - Verfahren zur herstellung von indolizinderivaten - Google Patents

Verfahren zur herstellung von indolizinderivaten

Info

Publication number
ATE173259T1
ATE173259T1 AT94925630T AT94925630T ATE173259T1 AT E173259 T1 ATE173259 T1 AT E173259T1 AT 94925630 T AT94925630 T AT 94925630T AT 94925630 T AT94925630 T AT 94925630T AT E173259 T1 ATE173259 T1 AT E173259T1
Authority
AT
Austria
Prior art keywords
producing
pct
indolicine
derivatives
date
Prior art date
Application number
AT94925630T
Other languages
English (en)
Inventor
Satoshi Okada
Kozo Sawada
Akio Kuroda
Shinya Watanabe
Hirokazu Tanaka
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of ATE173259T1 publication Critical patent/ATE173259T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT94925630T 1993-09-10 1994-09-06 Verfahren zur herstellung von indolizinderivaten ATE173259T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939318790A GB9318790D0 (en) 1993-09-10 1993-09-10 Heterocyclic derivatives

Publications (1)

Publication Number Publication Date
ATE173259T1 true ATE173259T1 (de) 1998-11-15

Family

ID=10741816

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94925630T ATE173259T1 (de) 1993-09-10 1994-09-06 Verfahren zur herstellung von indolizinderivaten

Country Status (12)

Country Link
US (1) US5780633A (de)
EP (1) EP0717742B1 (de)
JP (1) JP3160909B2 (de)
KR (1) KR100339068B1 (de)
CN (1) CN1043992C (de)
AT (1) ATE173259T1 (de)
CA (1) CA2171308A1 (de)
DE (1) DE69414586T2 (de)
ES (1) ES2127937T3 (de)
GB (1) GB9318790D0 (de)
HU (1) HU216156B (de)
WO (1) WO1995007279A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0934318A1 (de) * 1996-10-01 1999-08-11 Glycodesign Inc. 3,5 und/oder6-substituierte swainsonine analoga, verfahren zu ihrer herstellung und ihre therapeutische verwendung
US6395745B1 (en) 1997-04-15 2002-05-28 Glycodesign, Inc. Alkaloid halide salts of swainsonine and methods of use
CA2307595A1 (en) * 1997-10-24 1999-05-06 Glycodesign Inc. Synthesis of swainsonine salts
FR2838123B1 (fr) * 2002-04-04 2005-06-10 Sanofi Synthelabo Nouveaux derives d'indolozine-1,2,3 substituee, inhibiteurs selectifs du b-fgf
EP1807427A2 (de) 2004-11-01 2007-07-18 Wyeth Substituierte indolizine und derivate als zns-wirkstoffe

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3316272A (en) 1962-06-27 1967-04-25 Richardson Merrell Inc Heterocyclic derivatives of triphenyl-ethylenes, triphenylethanes and triphenylethanols
US3306895A (en) 1962-06-27 1967-02-28 Richardson Merrell Inc Heterocyclic derivatives of triphenylethylenes, triphenylethanes and triphenylethanols
US4000143A (en) 1971-03-03 1976-12-28 Mead Johnson & Company Substituted piperidines
US3931195A (en) 1971-03-03 1976-01-06 Mead Johnson & Company Substituted piperidines
US5334716A (en) * 1991-06-17 1994-08-02 Fujisawa Pharmaceutical Co., Ltd. Heterocyclic derivatives

Also Published As

Publication number Publication date
GB9318790D0 (en) 1993-10-27
CN1130907A (zh) 1996-09-11
EP0717742B1 (de) 1998-11-11
CN1043992C (zh) 1999-07-07
DE69414586D1 (de) 1998-12-17
JPH09502200A (ja) 1997-03-04
CA2171308A1 (en) 1995-03-16
ES2127937T3 (es) 1999-05-01
HUT74290A (en) 1996-11-28
KR100339068B1 (ko) 2002-11-23
EP0717742A1 (de) 1996-06-26
WO1995007279A2 (en) 1995-03-16
HU216156B (hu) 1999-04-28
US5780633A (en) 1998-07-14
WO1995007279A3 (en) 1995-04-27
DE69414586T2 (de) 1999-04-29
KR960704889A (ko) 1996-10-09
JP3160909B2 (ja) 2001-04-25
HU9600606D0 (en) 1996-05-28

Similar Documents

Publication Publication Date Title
ATE153332T1 (de) Verfahren zur herstellung von oxetanonen
TW263499B (de)
PT835257E (pt) Intermediarios e processo para o fabrico de derivados camptotecina (cpt-11) e compostos relacionados
PL295030A1 (en) Method of obtaining substituted derivatives of 2-cyclohexan-1-yl amine
ATE176472T1 (de) Verfahren zur herstellung von nalbuphin das wenig des 6-beta-epimers enthält
SE9502921D0 (sv) New compounds
DE69207429D1 (de) Verfahren zur herstellung von substituierten piperidinen
ATE187440T1 (de) Verfahren zur herstellung von substituierten 3- aminobenzonitrilen
DE69414586D1 (de) Verfahren zur herstellung von indolizinderivaten
ATE277887T1 (de) Verfahren zur herstellung von 1,4-bis((2- (dimethylamino)ethyl amino)-5,8- dihydroxyanthracene-9,10-dion
DE69808771D1 (de) Ein verfahren zur herstellung von tetraaza makrocyclen
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
ATE324366T1 (de) Verfahren zur herstellung von 3-pyrrolin-2- carbonsäure-derivaten
ATE186737T1 (de) Ein verbessertes verfahren für die herstellung von seitenketten-derivaten von cyclohexapeptidyl- lipopeptiden
DE58902228D1 (de) Verfahren zur herstellung von 5-gliedrigen, stickstoffhaltigen heteroaromaten.
ATE188694T1 (de) Verfahren zur herstellung von benzopyranderivaten
ATE205473T1 (de) Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
DE69627533D1 (de) Herstellung von einem kristallinen amoxicillinsalz
DE59409324D1 (de) Verfahren zur herstellung von 3-amino-2-chlor-4-alkyl- bzw. 4-cycloalkyl-pyridine
ATE215071T1 (de) Verfahren zur herstellung von prostaglandin e1
ATE187164T1 (de) Verfahren zur herstellung von ng-monoalkyl-l- arginin und verwandten verbindungen
DE69616801D1 (de) Eintopfverfahren zur herstellung von 2-oxazolidinonderivate

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties